Congressional Probe of Alzheimer’s Drug Approval Finds Fault With FDA Actions
The FDA broke with its own protocols in reviewing and subsequently approving Alzheimer’s drug aducanumab (Aduhelm), by inappropriately collaborating with drugmaker Biogen on briefing documents, holding unreported meetings, and failing to gain internal consensus before engaging in such collaborations, according to an in-depth congressional investigation of the interactions between the agency and the drugmaker. The […]
Lack of access to healthy food may raise risk of death from heart failure
A study reviewing data from nearly 3,000 counties in the United States has found that living in a community with easy access to grocery stores and affordable, healthy food is associated with lower heart failure death rates, according to new research published today in Circulation: Heart Failure, an American Heart Association journal. Food insecurity occurs […]
Lawmakers Press FDA on Getting ALS Therapies to Patients
House lawmakers urged the FDA to be more flexible in reviewing potential therapies for amyotrophic lateral sclerosis (ALS), and other neurodegenerative diseases, during a hearing of the House Energy & Commerce Health Subcommittee on Thursday. Members also stressed the need to increase diversity in and improve access to clinical trials. Each year, 50 million people […]